Posted On: 12/17/2014 3:32:51 PM
Post# of 30035
Not true. We got a number of updates on Eltoprazine as one example. Now if they waited until Christmas and said oops, that's isn't Q4, that's Q1, that wouldn't be great, but not the end of the world. If they said, we are going to put it on the shelf and look at it a few years from now, that would be very bad.
Oct. 27, 2014 - We are looking forward to receiving pre-IND feedback from the FDA later in the fourth quarter and being able to open a new IND in the Neurology Division of FDA shortly thereafter. The Phase 2b trial is on schedule to start in early 2015.
Oct. 27, 2014 - We previously outlined our intentions to initiate a Phase 2b trial for Eltoprazine in Adult ADHD following the initiation of the Phase 2b PD LID clinical trial, and we remain on track to achieve this as much of the groundwork for the Adult ADHD trial is being completed for the Phase 2b PD LID trial.
Oct. 27, 2014 - We are looking forward to receiving pre-IND feedback from the FDA later in the fourth quarter and being able to open a new IND in the Neurology Division of FDA shortly thereafter. The Phase 2b trial is on schedule to start in early 2015.
Oct. 27, 2014 - We previously outlined our intentions to initiate a Phase 2b trial for Eltoprazine in Adult ADHD following the initiation of the Phase 2b PD LID clinical trial, and we remain on track to achieve this as much of the groundwork for the Adult ADHD trial is being completed for the Phase 2b PD LID trial.
(0)
(0)Scroll down for more posts ▼
